β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Hypertrophic cardiomyopathy (HCM) affects 1 in 500 people and leads to hyper-contractility of the heart. Nearly 40 percent of HCM-causing mutations are found in human β-cardiac myosin. Previous studies looking at the effect of HCM mutations on the force, velocity and ATPase activity of the catalytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Adhikari, Arjun S., Trivedi, Darshan V., Sarkar, Saswata S., Song, Dan, Kooiker, Kristina B., Bernstein, Daniel, Spudich, James A., Ruppel, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582153/
https://www.ncbi.nlm.nih.gov/pubmed/31213605
http://dx.doi.org/10.1038/s41467-019-10555-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582153/
https://www.ncbi.nlm.nih.gov/pubmed/31213605
http://dx.doi.org/10.1038/s41467-019-10555-9

Ejemplares similares